Skip to main content

UK REACH deadlines to be extended

8th December 2022

Submitted by:

Andrew Warmington

Following consultation with stakeholders over the summer, the UK Department of Environment, Food & Rural Affairs (Defra) has decided to extend the deadline for registering substances with the Health and Safety Executive (HSE) under UK REACH, the legislation that replaces EU REACH, by three years. This is subject to consultation with devolved governments in Scotland and Wales. As a result, the new deadlines will be:

* 27 October 2026 for substances included on the EU REACH candidate list before UK REACH came into effect; carcinogenic, mutagenic or toxic for reproduction and manufactured or imported in quantities of 1 tonne/year or more; very toxic to aquatic life and manufactured or imported in quantities of 100 tonnes/year or more; and all substances manufactured or imported in quantities of 1,000 tonnes/year or more

* 27 October 2028 for substances added to the UK REACH candidate list before the 2023 submission deadline, or which are manufactured or imported in quantities of 100 tonnes/year or more

* 27 October 2030 for all substances manufactured or imported in quantities of 1 tonne/year or more

Defra stated that an extension was needed “to ensure there is sufficient time for substantive development of the policy, and to make operational and legislative changes to implement the new model” and also to give industry time to prepare for compliance while avoiding extra cost. Views were also sought on a proposal to make related amendments to the dates for compliance checks under Article 41(5) to ensure they were in lockstep with the proposed data submission deadlines. This would have been impossible under the previous deadlines.

In all, 289 responses were received. Of these, 123 were from large businesses (250+ employees), 47 from medium-sized businesses (50-249), 58 from small or micro businesses, 20 from consultants, 28 from an industry association, eight were from importers of substances and mixtures, and five from NGOs. Option 1, a three-year extension was decisively preferred over Option 2, the government’s preferred option of extending the deadlines by three years, two years and one year respectively, and Option 3, making no changes.

In all, 82% of those responding chose Option 1, most commonly saying “that it would provide more time to prepare registration documents and that the longer timeframe would reduce burdens and maximise the opportunity for businesses to submit high quality dossiers”. “

While we would like to see the data submitted in the shorter deadline provided under Option 2, we believe that the extra time under Option 1 could lessen potential burdens on businesses - especially SMEs and downstream users - without significantly impacting on human health and environmental protections,” Defra said. “We also recognise the potential for better quality data and maximising chances of compliance under Option 1.”

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington